JP2005534614A5 - - Google Patents

Download PDF

Info

Publication number
JP2005534614A5
JP2005534614A5 JP2003558035A JP2003558035A JP2005534614A5 JP 2005534614 A5 JP2005534614 A5 JP 2005534614A5 JP 2003558035 A JP2003558035 A JP 2003558035A JP 2003558035 A JP2003558035 A JP 2003558035A JP 2005534614 A5 JP2005534614 A5 JP 2005534614A5
Authority
JP
Japan
Prior art keywords
alkyl
optionally substituted
aryl
heteroaryl
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003558035A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005534614A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/000326 external-priority patent/WO2003057721A2/en
Publication of JP2005534614A publication Critical patent/JP2005534614A/ja
Publication of JP2005534614A5 publication Critical patent/JP2005534614A5/ja
Pending legal-status Critical Current

Links

JP2003558035A 2002-01-04 2003-01-06 アルツハイマー病治療のための置換アミノカルボキサミド Pending JP2005534614A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34531602P 2002-01-04 2002-01-04
US35041902P 2002-01-18 2002-01-18
PCT/US2003/000326 WO2003057721A2 (en) 2002-01-04 2003-01-06 Substituted amino carboxamides for the treatment of alzheimer's disease

Publications (2)

Publication Number Publication Date
JP2005534614A JP2005534614A (ja) 2005-11-17
JP2005534614A5 true JP2005534614A5 (cg-RX-API-DMAC7.html) 2006-03-16

Family

ID=26994342

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003558035A Pending JP2005534614A (ja) 2002-01-04 2003-01-06 アルツハイマー病治療のための置換アミノカルボキサミド

Country Status (8)

Country Link
US (1) US6962934B2 (cg-RX-API-DMAC7.html)
EP (1) EP1458745A2 (cg-RX-API-DMAC7.html)
JP (1) JP2005534614A (cg-RX-API-DMAC7.html)
AU (1) AU2003206413A1 (cg-RX-API-DMAC7.html)
BR (1) BR0306724A (cg-RX-API-DMAC7.html)
CA (1) CA2472617A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA04006575A (cg-RX-API-DMAC7.html)
WO (1) WO2003057721A2 (cg-RX-API-DMAC7.html)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003294441A1 (en) * 2002-11-22 2004-06-18 Bristol-Myers Squibb Company 1-aryl-2-hydroxyethyl amides as potassium channel openers
US7521481B2 (en) * 2003-02-27 2009-04-21 Mclaurin Joanne Methods of preventing, treating and diagnosing disorders of protein aggregation
JP2007516207A (ja) * 2003-06-30 2007-06-21 メルク　エンド　カムパニー　インコーポレーテッド アルツハイマー病の治療のためのＮ−アルキルフェニルカルボキサミドβ−セクレターゼ阻害剤
EP1694635A2 (en) * 2003-10-30 2006-08-30 Elan Pharmaceuticals, Inc. HYDROXYPROPYL AMIDES FOR THE TREATMENT OF ALZHEIMER’S DISEASE
JP2007517781A (ja) 2003-12-19 2007-07-05 メルク　エンド　カムパニー　インコーポレーテッド アルツハイマー病治療用のフェニルアミドおよびピリジルアミド系β−セクレターゼ阻害薬
US20060014790A1 (en) * 2004-01-21 2006-01-19 Varghese John Methods of treatment of amyloidosis using spirocyclohexane aspartyl-protease inhibitors
US7847100B2 (en) 2004-04-20 2010-12-07 Merck, Sharp & Dohme, Inc. 1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's disease
AU2005236063A1 (en) 2004-04-20 2005-11-03 Merck & Co., Inc. 2, 4, 6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's disease
WO2005113582A1 (en) * 2004-05-22 2005-12-01 Boehringer Ingelheim International Gmbh Substituted ethane-1,2-diamines for the treatment of alzheimer's disease
EP1758854B1 (en) * 2004-06-15 2014-07-16 Merck Sharp & Dohme Corp. Pyrrolidin-3-yl compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
CA2603404A1 (en) 2005-03-30 2006-10-05 Boehringer Ingelheim International Gmbh Substituted 1,2-ethylendiamines, medicaments comprising said compound; their use and their method of manufacture
MX2007012341A (es) 2005-04-08 2008-02-12 Comentis Inc Compuestos que inhiben actividad beta-secretasa y metodos de uso de los mismos.
EP1919861A2 (de) * 2005-08-11 2008-05-14 Boehringer Ingelheim International GmbH Verbindungen zur behandlung der alzheimer erkrankung
US20090042867A1 (en) * 2005-08-11 2009-02-12 Klaus Fuchs Compounds for the treatment of alzheimer's disease
CA2618474A1 (en) * 2005-08-11 2007-02-15 Boehringer Ingelheim International Gmbh Compounds for treating alzheimer's disease
EP1915339A1 (de) * 2005-08-11 2008-04-30 Boehringer Ingelheim International GmbH Inhibitoren der beta-sekretase zur behandlung der alzheimer- erkrankung
US7872009B2 (en) 2005-11-21 2011-01-18 Amgen Inc. Beta-Secretase modulators and methods of use
US7838676B2 (en) * 2005-11-21 2010-11-23 Amgen Inc. Beta-secretase modulators and methods of use
EP1971598A1 (en) 2005-11-21 2008-09-24 Amgen Inc. Beta-secretase modulators and methods of use
US7745484B2 (en) 2005-11-21 2010-06-29 Amgen Inc. Beta-secretase modulators and methods of use
CL2008001500A1 (es) 2007-05-25 2008-12-26 Amgen Inc Compuestos derivados de hidroxietil amina sustituidas, moduladores de betasecretasa; proceso de preparacion de dichos c ompuestos; composicion farmaceutica que los comprende; y su uso para tratar un trastorno neurologico, tal como alzheimer, sindrome de down, demencia degenerativa, entre otros.
CA2687608C (en) 2007-05-25 2013-07-02 Amgen Inc. Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
JP5450407B2 (ja) 2007-07-06 2014-03-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 置換アミノ−キナゾリノン、前記化合物を含む薬物、それらの使用及び製造方法
US7803809B2 (en) 2008-11-12 2010-09-28 Amgen Inc. Substituted pyrano [2,3-b] pyridinamine compounds as beta-secretase modulators and methods of use
MX2011002705A (es) * 2008-09-11 2011-09-09 Amgen Inc Compuestos con anillos espiro-triciclicos como moduladores de beta-secretasas y metodos de uso.
US8822485B2 (en) 2009-11-23 2014-09-02 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
WO2011063233A1 (en) 2009-11-23 2011-05-26 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
WO2011090911A1 (en) 2010-01-19 2011-07-28 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
MX2012010658A (es) 2010-03-15 2012-12-05 Amgen Inc Compuestos de anillo espiro tetraciclico como moduladores de beta-secretasa.
US8497264B2 (en) 2010-03-15 2013-07-30 Amgen Inc. Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
US9346827B2 (en) 2011-02-07 2016-05-24 Amgen Inc. 5-amino-oxazepine and 5-amino-thiazepane compounds as beta secretase antagonists and methods of use
WO2013044092A1 (en) 2011-09-21 2013-03-28 Amgen Inc. Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
US9725469B2 (en) 2012-11-15 2017-08-08 Amgen, Inc. Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696270A (en) 1989-05-23 1997-12-09 Abbott Laboratories Intermediate for making retroviral protease inhibiting compounds
US5362912A (en) 1989-05-23 1994-11-08 Abbott Laboratories Process for the preparation of a substituted diaminodiol
US5352705A (en) * 1992-06-26 1994-10-04 Merck & Co., Inc. Inhibitors of farnesyl protein transferase
DE69334250D1 (de) 1992-12-29 2009-01-29 Abbott Lab Verfahren und Intermediate zur Herstellung von retroviralen Proteasehemmern
JPH11507538A (ja) 1995-06-07 1999-07-06 アテナ ニューロサイエンシズ インコーポレイティド β−セクレターゼ、β−セクレターゼに対する抗体、及びβ−セクレターゼ阻害を検出するためのアッセイ
AU4329499A (en) * 1998-07-30 2000-02-21 Warner-Lambert Company Reduced dipeptide analogues as calcium channel antagonists
JP2003502342A (ja) 1999-06-15 2003-01-21 エラン ファーマスーティカルズ インコーポレイテッド ベータ−セクレターゼのスタチン誘導テトラペプチド阻害剤

Similar Documents

Publication Publication Date Title
JP2004532894A5 (cg-RX-API-DMAC7.html)
JP2005505506A5 (cg-RX-API-DMAC7.html)
JP2006501295A5 (cg-RX-API-DMAC7.html)
JP2005533811A5 (cg-RX-API-DMAC7.html)
JPH03170411A (ja) アミノメルカプトアルキルアミドまたはその塩を還元剤とする髪の永続変形用還元組成物
JP2557805B2 (ja) 美容用組成物およびパーマネント処理方法
JPH05279322A (ja) 新規なアルキルアミノ−メルカプトアルキルアミド、その製造方法及びこれを含有する化粧料組成物
JP2010524975A5 (cg-RX-API-DMAC7.html)
JP2004534064A5 (cg-RX-API-DMAC7.html)
JP2014503525A5 (cg-RX-API-DMAC7.html)
RU2005107314A (ru) Пиримидопроизводные, характеризующиеся антипролиферативной активностью
JP6270848B2 (ja) ベータ−クロロシクロペンタンの親水性エステルプロドラッグの使用による角膜中央部肥厚の低下
CN1183268A (zh) 洗涤剂组合物
JP2005514330A5 (cg-RX-API-DMAC7.html)
JPH0436224A (ja) シャンプー組成物
KR20100131976A (ko) 고 안압증의 치료를 위한 디플루오로바이페닐아미드 유도체
JPH07165703A (ja) 緑内障及び高眼圧治療用局所眼薬組成物
RU2015104969A (ru) Производные пиридинона в качестве ингибиторов трансглутаминазы тканей
JP2021527721A5 (cg-RX-API-DMAC7.html)
JP2006508090A5 (cg-RX-API-DMAC7.html)
JP2016222670A (ja) 洗浄剤組成物
WO2012102355A1 (ja) 二環式化合物およびその医薬用途
JPH10121091A (ja) 洗浄剤組成物
RU2004115626A (ru) Новые производные норборнана и норборнена, их применение и содержащие их ароматные продукты
RU2019128576A (ru) Сокристаллы замещенных глициновых соединений и их применение